BNP Paribas Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
223,391
+89,143
| +66% | +$4.9M | 0.03% | 423 |
|
|
2025
Q1 | $9.5M | Buy |
134,248
+840
| +0.6% | +$59.5K | 0.03% | 455 |
|
|
2024
Q4 | $8.77M | Sell |
133,408
-20,755
| -13% | -$1.36M | 0.02% | 468 |
|
|
2024
Q3 | $10.8M | Sell |
154,163
-390,933
| -72% | -$27.5M | 0.03% | 421 |
|
|
2024
Q2 | $44.9M | Sell |
545,096
-252,669
| -32% | -$20.8M | 0.12% | 188 |
|
|
2024
Q1 | $69.7M | Buy |
797,765
+466,544
| +141% | +$40.7M | 0.19% | 127 |
|
|
2023
Q4 | $31.9M | Sell |
331,221
-257,722
| -44% | -$24.8M | 0.09% | 242 |
|
|
2023
Q3 | $52.1M | Buy |
588,943
+400,055
| +212% | +$35.4M | 0.16% | 159 |
|
|
2023
Q2 | $16.4M | Buy |
188,888
+8,984
| +5% | +$779K | 0.05% | 312 |
|
|
2023
Q1 | $17.5M | Buy |
179,904
+68,965
| +62% | +$6.71M | 0.06% | 317 |
|
|
2022
Q4 | $11.5M | Sell |
110,939
-60,275
| -35% | -$6.24M | 0.04% | 398 |
|
|
2022
Q3 | $14.5M | Sell |
171,214
-38,380
| -18% | -$3.25M | 0.06% | 347 |
|
|
2022
Q2 | $17.4M | Sell |
209,594
-5,785
| -3% | -$479K | 0.07% | 308 |
|
|
2022
Q1 | $16.6M | Buy |
215,379
+25,833
| +14% | +$1.99M | 0.06% | 331 |
|
|
2021
Q4 | $16.7M | Buy |
189,546
+2,220
| +1% | +$196K | 0.06% | 353 |
|
|
2021
Q3 | $14.5M | Buy |
187,326
+35,133
| +23% | +$2.72M | 0.05% | 351 |
|
|
2021
Q2 | $12.7M | Buy |
152,193
+10,564
| +7% | +$881K | 0.05% | 400 |
|
|
2021
Q1 | $10.7M | Buy |
141,629
+11,428
| +9% | +$863K | 0.04% | 401 |
|
|
2020
Q4 | $11.4M | Sell |
130,201
-39,447
| -23% | -$3.46M | 0.05% | 359 |
|
|
2020
Q3 | $12.9M | Buy |
169,648
+73,578
| +77% | +$5.6M | 0.07% | 283 |
|
|
2020
Q2 | $11.8M | Sell |
96,070
-46,963
| -33% | -$5.79M | 0.08% | 277 |
|
|
2020
Q1 | $12.1M | Sell |
143,033
-2,871
| -2% | -$243K | 0.1% | 229 |
|
|
2019
Q4 | $12.3M | Buy |
145,904
+14,973
| +11% | +$1.27M | 0.08% | 285 |
|
|
2019
Q3 | $8.83M | Buy |
130,931
+12,475
| +11% | +$841K | 0.07% | 321 |
|
|
2019
Q2 | $10.1M | Sell |
118,456
-28,282
| -19% | -$2.42M | 0.08% | 293 |
|
|
2019
Q1 | $13M | Buy |
146,738
+38,968
| +36% | +$3.46M | 0.11% | 241 |
|
|
2018
Q4 | $9.01M | Sell |
107,770
-22,557
| -17% | -$1.89M | 0.08% | 301 |
|
|
2018
Q3 | $12.6M | Sell |
130,327
-150,451
| -54% | -$14.6M | 0.1% | 284 |
|
|
2018
Q2 | $26.4M | Sell |
280,778
-8,566
| -3% | -$807K | 0.22% | 116 |
|
|
2018
Q1 | $23.5M | Buy |
289,344
+3,775
| +1% | +$306K | 0.2% | 141 |
|
|
2017
Q4 | $25.5M | Buy |
285,569
+63,631
| +29% | +$5.67M | 0.22% | 113 |
|
|
2017
Q3 | $20.7M | Sell |
221,938
-85,745
| -28% | -$7.98M | 0.17% | 148 |
|
|
2017
Q2 | $27.9M | Buy |
307,683
+110,217
| +56% | +$10M | 0.25% | 91 |
|
|
2017
Q1 | $17.3M | Buy |
197,466
+39,051
| +25% | +$3.43M | 0.16% | 162 |
|
|
2016
Q4 | $13.1M | Buy |
158,415
+18,056
| +13% | +$1.5M | 0.13% | 215 |
|
|
2016
Q3 | $13M | Sell |
140,359
-11,096
| -7% | -$1.03M | 0.11% | 250 |
|
|
2016
Q2 | $11.8M | Sell |
151,455
-20,332
| -12% | -$1.58M | 0.1% | 278 |
|
|
2016
Q1 | $14.2M | Sell |
171,787
-77,848
| -31% | -$6.42M | 0.12% | 238 |
|
|
2015
Q4 | $26.2M | Buy |
249,635
+158,083
| +173% | +$16.6M | 0.22% | 126 |
|
|
2015
Q3 | $9.64M | Buy |
91,552
+45,947
| +101% | +$4.84M | 0.08% | 319 |
|
|
2015
Q2 | $6.24M | Sell |
45,605
-12,054
| -21% | -$1.65M | 0.05% | 446 |
|
|
2015
Q1 | $7.19M | Buy |
57,659
+46,074
| +398% | +$5.74M | 0.05% | 388 |
|
|
2014
Q4 | $1.05M | Buy |
+11,585
| New | +$1.05M | 0.01% | 743 |
|
|
2014
Q2 | – | Sell |
-26,348
| Closed | -$1.8M | – | 942 |
|
|
2014
Q1 | $1.8M | Sell |
26,348
-27,589
| -51% | -$1.88M | 0.01% | 670 |
|
|
2013
Q4 | $3.79M | Buy |
+53,937
| New | +$3.79M | 0.03% | 467 |
|